GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pacira BioSciences Inc (NAS:PCRX) » Definitions » E10

Pacira BioSciences (Pacira BioSciences) E10 : $0.26 (As of Dec. 2023)


View and export this data going back to 2011. Start your Free Trial

What is Pacira BioSciences E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Pacira BioSciences's adjusted earnings per share data for the three months ended in Dec. 2023 was $0.520. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $0.26 for the trailing ten years ended in Dec. 2023.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Pacira BioSciences was 75.30% per year. The lowest was 74.10% per year. And the median was 74.70% per year.

As of today (2024-04-27), Pacira BioSciences's current stock price is $26.33. Pacira BioSciences's E10 for the quarter that ended in Dec. 2023 was $0.26. Pacira BioSciences's Shiller PE Ratio of today is 101.27.

During the past 13 years, the highest Shiller PE Ratio of Pacira BioSciences was 500.88. The lowest was 97.27. And the median was 176.69.


Pacira BioSciences E10 Historical Data

The historical data trend for Pacira BioSciences's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pacira BioSciences E10 Chart

Pacira BioSciences Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -5.33 -0.72 -0.32 -0.08 0.26

Pacira BioSciences Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.08 -0.03 0.08 0.16 0.26

Competitive Comparison of Pacira BioSciences's E10

For the Drug Manufacturers - Specialty & Generic subindustry, Pacira BioSciences's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pacira BioSciences's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Pacira BioSciences's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Pacira BioSciences's Shiller PE Ratio falls into.



Pacira BioSciences E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Pacira BioSciences's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=0.52/129.4194*129.4194
=0.520

Current CPI (Dec. 2023) = 129.4194.

Pacira BioSciences Quarterly Data

per share eps CPI Adj_EPS
201403 -0.340 99.695 -0.441
201406 -0.140 100.560 -0.180
201409 -0.080 100.428 -0.103
201412 0.140 99.070 0.183
201503 0.030 99.621 0.039
201506 0.000 100.684 0.000
201509 0.080 100.392 0.103
201512 -0.070 99.792 -0.091
201603 -0.100 100.470 -0.129
201606 -0.210 101.688 -0.267
201609 -0.590 101.861 -0.750
201612 -0.110 101.863 -0.140
201703 -0.520 102.862 -0.654
201706 -0.490 103.349 -0.614
201709 -0.190 104.136 -0.236
201712 0.110 104.011 0.137
201803 -0.260 105.290 -0.320
201806 0.060 106.317 0.073
201809 -0.020 106.507 -0.024
201812 0.200 105.998 0.244
201903 -0.070 107.251 -0.084
201906 0.060 108.070 0.072
201909 -0.150 108.329 -0.179
201912 -0.120 108.420 -0.143
202003 0.190 108.902 0.226
202006 -0.170 108.767 -0.202
202009 2.940 109.815 3.465
202012 0.320 109.897 0.377
202103 0.230 111.754 0.266
202106 0.420 114.631 0.474
202109 0.390 115.734 0.436
202112 -0.120 117.630 -0.132
202203 0.150 121.301 0.160
202206 0.400 125.017 0.414
202209 -0.020 125.227 -0.021
202212 -0.220 125.222 -0.227
202303 -0.430 127.348 -0.437
202306 0.510 128.729 0.513
202309 0.230 129.860 0.229
202312 0.520 129.419 0.520

Add all the adjusted EPS together and divide 10 will get our e10.


Pacira BioSciences  (NAS:PCRX) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Pacira BioSciences's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=26.33/0.26
=101.27

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Pacira BioSciences was 500.88. The lowest was 97.27. And the median was 176.69.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Pacira BioSciences E10 Related Terms

Thank you for viewing the detailed overview of Pacira BioSciences's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Pacira BioSciences (Pacira BioSciences) Business Description

Traded in Other Exchanges
Address
5401 West Kennedy Boulevard, Suite 890, Tampa, FL, USA, 33609
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company has launched EXPAREL which utilizes DepoFoam, a product delivery technology that encapsulates drugs without altering their molecular structure, and releases them over a desired period of time.
Executives
Marcelo Bigal director C/O PACIRA BIOSCIENCES, INC., 5401 WEST KENNEDY BOULEVARD, SUITE 890, TAMPA FL 33609
Abraham Ceesay director C/O SCPHARMACEUTICALS, INC., 2400 DISTRICT AVENUE SUITE 310, BURLINGTON MA 01830
Alethia Young director C/O GRAPHITE BIO, INC., 201 HASKINS WAY, SUITE 210, SOUTH SAN FRANCISCO CA 94080
Michael J. Yang director C/O ACADIA PHARMACEUTICALS INC., 12830 EL CAMINO REAL, SUITE 400, SAN DIEGO CA 92130
Roy Winston officer: Chief Clinical Officer C/O PACIRA BIOSCIENCES, INC,, 5401 WEST KENNEDY BOULEVARD, SUITE 890, TAMPA FL 33609
Lauren Bullaro Riker officer: Executive Director, Accounting C/O PACIRA PHARMACEUTICALS, INC., 5 SYLVAN WAY, PARSIPPANY NJ 07054
Kristen Marie Williams officer: CAO and General Counsel C/O PACIRA PHARMACEUTICALS, INC., 5 SYLVAN WAY, SUITE 300, PARSIPPANY NJ 07054
Mark A. Kronenfeld director C/O PACIRA PHARMACEUTICALS, INC., 5 SYLVAN WAY, SUITE 100, PARSIPPANY NJ 07054
Daryl Gaugler officer: Chief Operating Officer C/O PACIRA BIOSCIENCES, INC., 5 SYLVAN WAY, SUITE 300, PARSIPPANY NJ 07054
Reinhart Charles A. Iii officer: Chief Financial Officer C/O PACIRA PHARMACEUTICALS, INC., 5 SYLVAN WAY, SUITE 300, PARSIPPANY NJ 07054
Ellis Ronald J. Jr. officer: Chief Strategy Officer C/O TELA BIO, INC., 1 GREAT VALLEY PARKWAY, SUITE 24, MALVERN PA 19355
Max Reinhardt officer: President C/O PACIRA BIOSCIENCES, INC., 5 SYLVAN WAY, SUITE 300, PARSIPPANY NJ 07054
David M Stack director, officer: President and CEO THE MEDICINES CO, 8 CAMPUS DRIVE, PARSIPPANY NJ 07054
Dennis Mcloughlin officer: Chief Commercial Officer C/O PACIRA PHARMACEUTICALS, INC., 5 SYLVAN WAY, SUITE 300, PARSIPPANY NJ 07054
Jonathan Slonin officer: Chief Clinical Officer C/O PACIRA BIOSCIENCES, INC., 5 SYLVAN WAY, SUITE 300, PARSIPPANY NJ 07054